Ligand validation:3E81

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3E81_EDO_A_167	81%	89%	0.084	0.936	0.46	0.19	-	-	0	0	100%	1
3E81_EDO_A_168	57%	87%	0.107	0.88	0.44	0.25	-	-	0	0	100%	1
3E81_EDO_C_168	35%	79%	0.122	0.81	0.48	0.38	-	-	0	0	100%	1
3E81_EDO_A_169	33%	80%	0.159	0.835	0.47	0.37	-	-	0	0	100%	1
3E81_EDO_B_168	30%	86%	0.112	0.77	0.48	0.25	-	-	0	0	100%	1
3E81_EDO_C_167	1%	88%	0.335	0.542	0.51	0.18	-	-	3	0	100%	1
3E8M_EDO_A_173	20%	75%	0.314	0.917	0.64	0.36	-	-	1	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.